UCrest Bhd (XKLS:0005) Revenue: RM13.96 Mil (TTM As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is UCrest Bhd Revenue?

UCrest Bhd XKLS:0005 -7.14% Revenue is RM13.96 Mil as of May. 2026. The stock has 4 warning signs investors should review.

UCrest Bhd's revenue for the three months ended in May. 2026 was RM4.26 Mil. Its revenue for the trailing twelve months (TTM) ended in May. 2026 was RM13.96 Mil. UCrest Bhd's Revenue per Share for the three months ended in May. 2026 was RM0.01. Its Revenue per Share for the trailing twelve months (TTM) ended in May. 2026 was RM0.02.

Warning Sign:

UCrest Bhd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of UCrest Bhd was -24.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -3.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was -10.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 1.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, UCrest Bhd's highest 3-Year average Revenue per Share Growth Rate was 169.20% per year. The lowest was -43.30% per year. And the median was -0.50% per year.


UCrest Bhd  (XKLS:0005) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


UCrest Bhd Revenue Related Terms


UCrest Bhd Revenue Historical Data

* Premium members only.

The historical data trend for UCrest Bhd's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UCrest Bhd Revenue Chart

UCrest Bhd Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.35 13.56 15.93 18.44 13.96

UCrest Bhd Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.66 3.31 2.79 3.59 4.26

XKLS:0005 vs VEEV, BTSG, TEM: Revenue Comparison

For the Health Information Services subindustry, UCrest Bhd's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UCrest Bhd Revenue vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, UCrest Bhd's Revenue distribution charts can be found below:

* The bar in red indicates where UCrest Bhd's Revenue falls into.



UCrest Bhd Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM13.96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of RM13.96 Mil mean?
UCrest Bhd (XKLS:0005) has a Revenue of RM13.96 Mil as of May. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on UCrest Bhd and its competitors.
Is UCrest Bhd's Revenue too high?
UCrest Bhd's current Revenue is RM13.96 Mil.
How does UCrest Bhd's Revenue compare to VEEV and BTSG?
UCrest Bhd's Revenue of RM13.96 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on UCrest Bhd and its competitors. UCrest Bhd's current Revenue is RM13.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UCrest Bhd stock overvalued right now?
Based on GuruFocus' analysis, UCrest Bhd (XKLS:0005) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.08, compared to a current price of RM0.07 — trading 18.8% below its estimated fair value. The current Revenue is RM13.96 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For UCrest Bhd (XKLS:0005), the current Revenue is RM13.96 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

UCrest Bhd Business Description

Address 8, First Avenue, Bandar Utama, 6th Floor, Unit 4, Petaling Jaya, SGR, MYS, 47800
UCrest Bhd is a technology provider company that engages in network design, product development, and software development. The firm provider of Cloud Hospital and mobile health services. The company offers an i-Medic platform for diagnosis, management, and treatment of chronic diseases such as cardiovascular diseases (CVD), cancer, diabetes, hypertension, sleep apnea, stroke rehabilitation, and other diseases.